Monday's Winners & Losers: Marvel
Alfa agreed to a going-private deal with its majority shareholder, Alfa Mutual. The deal will pay Alfa investors $22 a share, a 26% premium over Friday's closing price. The purchase has a total value of $840 million. Shares of Alfa, an insurance concern, were up $3.99 to $21.51.
Among losers, Cardinal Health (CAH) shed nearly 7% after the medical-products distributor warned of weakening results at its biggest unit. For the third quarter, Cardinal posted adjusted earnings from continuing operations of $318 million, or 86 cents a share, matching estimates. The company also backed its outlook for the full year.
Cardinal said, however, that its health care supply chain services-pharmaceutical segment is expected to have a full-year profit below its long-term goal of 7% to 10% growth. Mark Parrish, who led that division, is leaving the company immediately, Cardinal said. Shares were sliding $4.26 to $62.65.
Nu Skin Enterprises (NUS) dropped 7.9% after the company's revenue outlook disappointed investors. The company, a maker of personal care and nutritional products, posted third-quarter earnings of $13.5 million, or 21 cents a share, including 5 cents a share in one-time costs tied to a distributor convention. Revenue totaled $290.7 million. Analysts expected earnings of 23 cents a share and revenue of $287 million.Looking ahead, Nu Skin projected fourth-quarter revenue of $295 million to $300 million, below Wall Street's forecast of $302 million. For 2008, the company anticipates revenue of $1.18 billion to $1.2 billion, also shy of analysts' $1.22 billion projection. The stock was down $1.34 to $15.62.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV